EUVIMEDEUVIMED entdecken
Fallbericht

Pilocytic astrocytoma harboring a novel GNAI3‐BRAF fusion

Ruihe Lin iD, Alicia Kenyon, Zi-Xuan Wang, Jingli Cai, Lorraine Iacovitti, Lawrence C Kenyon iD

Neuropathology · 2023

DOI: 10.1111/neup.12896 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Neuropathology, 2023. Verfasst von Ruihe Lin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Anatomy, and Cell Biology, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Astrocytoma, Central Nervous System Neoplasms, Brain Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pilocytic astrocytoma (PA), a central nervous system (CNS) World Health Organization grade 1 tumor, is mainly seen in children or young adults aged 5–19. Surgical resection often provides excellent outcomes, but residual tumors may still remain. This low‐grade tumor is well recognized for its classic radiological and morphological features; however, some unique molecular findings have been unveiled by the application of next‐generation sequencing (NGS). Among the genetic abnormalities identified in this low‐grade tumor, increasing evidence indicates that BRAF alterations, especially BRAF fusions, play an essential role in PA tumorigenesis. Among the several fusion partner genes identified in PAs, KIAA1549‐BRAF fusion is notably the most common detectable genetic alteration, especially in the cerebellar PAs. Here, we report a case of a young adult patient with a large, right‐sided posterior fossa cerebellar and cerebellopontine angle region mass consistent with a PA. Of note, NGS detected a novel GNAI3‐BRAF fusion, which results in an in‐frame fusion protein containing the kinase domain of BRAF . This finding expands the knowledge of BRAF fusions in the tumorigenesis of PAs, provides an additional molecular signature for diagnosis, and a target for future therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AstrocytomaCentral Nervous System NeoplasmsBrain NeoplasmsChildYoung AdultHumansProto-Oncogene Proteins B-rafMutationCarcinogenesisGTP-Binding Protein alpha Subunits, Gi-Go

Stichwörter der Autor:innen

BRAF fusionGNAI3gliomagenesisnext-generation sequencing (NGS)pilocytic astrocytoma

Substanzen

Proto-Oncogene Proteins B-rafBRAF protein, humanGNAI3 protein, humanGTP-Binding Protein alpha Subunits, Gi-Go

Autor:innen und Institutionen

  • Department of Pathology, Anatomy, and Cell Biology, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA.
  • Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
  • Department of Neuroscience, Vickie and Jack Farber Institute for Neuroscience, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA.

ORCID-Profile: Ruihe Lin, Lawrence C Kenyon

Zitieren

APA

Lin, R., Kenyon, A., Wang, Z. X., Cai, J., Iacovitti, L., & Kenyon, L. C. (2023). Pilocytic astrocytoma harboring a novel GNAI3‐BRAF fusion. Neuropathology. https://doi.org/10.1111/neup.12896

Vancouver

Lin R, Kenyon A, Wang ZX, Cai J, Iacovitti L, Kenyon LC. Pilocytic astrocytoma harboring a novel GNAI3‐BRAF fusion. Neuropathology. 2023. doi:10.1111/neup.12896

BibTeX
@article{Lin2023,
  author = {Lin, Ruihe and Kenyon, Alicia and Wang, Zi-Xuan and Cai, Jingli and Iacovitti, Lorraine and Kenyon, Lawrence C},
  title = {Pilocytic astrocytoma harboring a novel GNAI3‐BRAF fusion},
  journal = {Neuropathology},
  year = {2023},
  doi = {10.1111/neup.12896}
}
Kostenlos starten →